STUDENT WORK IN HUMAN SUBJECTS PROTECTION
SOUGHT FOR FDA CONFERENCE AT UH
Call for Abstracts Concentrates on Showcasing
Fresh Work by Students Across Nation
HOUSTON, March 23, 2005 – From glucometers used by diabetics
to stents used by cardiologists, new medical devices inevitably
must be tested on human subjects. A national conference is seeking
student work in the field of contemporary human subjects protection.
Co-sponsored by the Food and Drug Administration and the University
of Houston, the April 21-22 event is one of only three annual conferences
sponsored by the U.S. Department of Health and Human Services’
Office of Human Research Protections (OHRP). Titled “The Critical
Path to New Medical Products: The Challenges in Protecting Human
Subjects,” the theme is directed at exploring the FDA critical
pathway for approval of new medical products and will be held at
the Hilton UH Hotel and Conference Center.
“In order to promote the next generation who will oversee
the protection of human subjects in research, we are calling for
abstracts on the topic to be presented at poster sessions both days
of the conference,” said Isaac D. Montoya, clinical professor
in the UH College of Pharmacy. “We intentionally limited the
poster session to students so that they have the opportunity to
showcase their work to a group of senior researchers. We want to
highlight and encourage work in this field and are interested in
any work students are doing or have done in the area of protecting
human subjects, ethics and other related topic areas.”
Medical and clinical papers also will be accepted, but only if they
somehow have to do with protecting human subjects specifically in
research. The deadline for submissions is Friday, April 15. Abstracts
are submitted online (http://www.uh.edu/pharmacy/ohrp/callforabstracts.htm),
and those wishing to submit must also register for the conference
(http://www.uh.edu/pharmacy/ohrp/register.htm).
While the poster may be one that has been presented at a recent
scientific meeting or will be presented at an upcoming meeting,
the research or work described by the poster should address protection
of human subjects in research and may target one of the categories
of the breakout sessions (http://www.uh.edu/pharmacy/ohrp/agenda.htm).
The contents of the abstract and poster must present actual research
and not simply a product description or announcement.
The conference will explore options to meet the considerable challenges
in protecting human subjects during research. Participants will
hear contemporary issues facing biomedical researchers, be provided
with an update on the regulations and gain insight to the challenges,
issues and potential solutions facing government and the private
sector while conducting research involving human subjects.
Open to both graduate and undergraduate students, the conference
will provide students with a forum to mingle with principal investigators,
research staff and coordinators, those involved in institutional
review boards, institutional officials, pharmaceutical research
personnel and medical personnel with an interest in human subjects
protection.
Key figures, offering a wide range of perspectives from the federal
government, private industry and academia, will give presentations
on topics such as the use of unapproved devices, bioterrorism, space
research, FDA monitoring and sanctions and new issues arising with
the developing field of bionanotechnology. Among the speakers will
be top Texas Medical Center representatives and faculty from UH,
The University of Texas Health Science Center, Baylor College of
Medicine, Christus Health and M.D. Anderson Cancer Center, as well
as CEO’s from MicroMed Technology, Pharma Frontiers and BioHouston.
Notable presenters and panelists include OHRP Director Bernard A.
Schwetz, D.V.M, David A. Lepay, M.D., senior adviser for clinical
science at the FDA and Charles F. Sawin, the chief NASA scientist
and leader of the International Space Station serving as chair of
the Committee for Protection of Human Subjects and chair of the
Human Research Multilateral Review Board at NASA’s Johnson
Space Center.
For additional conference information, visit www.uh.edu/pharmacy/ohrp
or call 713-795-8387.
About the University of Houston
The University of Houston, Texas’ premier metropolitan research
and teaching institution, is home to more than 40 research centers
and institutes and sponsors more than 300 partnerships with corporate,
civic and governmental entities. UH, the most diverse research university
in the country, stands at the forefront of education, research and
service with more than 35,000 students.
About the UH College of Pharmacy
For more than 50 years, the University of Houston College of Pharmacy
has shaped aspiring pharmacists, scientists and teachers. The college
offers a Pharm. D. degree, a master’s in pharmacy administration,
a Ph.D. in pharmaceutics or pharmacology and combined Pharm.D./Ph.D.
degrees. Accredited by the American Council on Pharmaceutical Education,
it is one of nearly 90 pharmacy colleges in the United States, with
more than 45 basic science and clinical faculty, nearly 610 adjunct
faculty and preceptors and 900 current pre-pharmacy and professional
students. The college has facilities both on the UH campus and in
the Texas Medical Center. At TMC, students have the opportunity
to train with physicians, medical students and members of UH clinical
faculty. In addition to faculty and staff offices, TMC also houses
research laboratories, classrooms and the Contemporary Pharmacy
Practice Laboratory.
To receive UH science news via e-mail, visit www.uh.edu/admin/media/sciencelist.html.
For more information about UH visit the universitys Newsroom at www.uh.edu/admin/media/newsroom.
|